These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22231608)

  • 1. Aspirin therapy in primary prevention: comment on "effect of aspirin on vascular and nonvascular outcomes".
    Mora S
    Arch Intern Med; 2012 Feb; 172(3):217-8. PubMed ID: 22231608
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin in the primary prevention of cardiovascular disease.
    Hennekens CH; Buring JE
    Cardiol Clin; 1994 Aug; 12(3):443-50. PubMed ID: 7805078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for primary prevention of cardiovascular disease?
    Drug Ther Bull; 2009 Nov; 47(11):122-5. PubMed ID: 19887685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing the science of aspirin in primary prevention of vascular events.
    Cardiovasc J Afr; 2007; 18(5):347-8. PubMed ID: 17985039
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin as preventive therapy in patients with asymptomatic vascular disease.
    Berger JS
    JAMA; 2010 Mar; 303(9):880-2. PubMed ID: 20197537
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aspirin in primary prevention of cardiovascular events in women and men (a meta-analysis of randomized controlled trials)].
    Iavelov IS
    Kardiologiia; 2006; 46(3):75-6. PubMed ID: 16710263
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
    Berger JS; Krantz MJ; Kittelson JM; Hiatt WR
    JAMA; 2009 May; 301(18):1909-19. PubMed ID: 19436018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Don't use aspirin for primary prevention of cardiovascular disease.
    Barnett H; Burrill P; Iheanacho I
    BMJ; 2010 Apr; 340():c1805. PubMed ID: 20410163
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin for primary prevention of cardiovascular disease (revisited).
    Med Lett Drugs Ther; 2006 Jul; 48(1238):53. PubMed ID: 16841021
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.
    Younis N; Williams S; Soran H
    Diabetes Obes Metab; 2009 Nov; 11(11):997-1000. PubMed ID: 19531055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary cardiovascular prevention with aspirin].
    Seguí Díaz M; Escobar C; Divisón JA
    Semergen; 2015; 41(5):279-81. PubMed ID: 25622997
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
    Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
    JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin for the prevention of cardiovascular events in the elderly.
    Mahé I; Leizorovicz A; Caulin C; Bergmann JF
    Drugs Aging; 2003; 20(13):999-1010. PubMed ID: 14561103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention].
    Volpe M; Abrignani MG; Borghi C; Coccheri S; Gresele P; Patti G; Trimarco B; De Caterina R
    G Ital Cardiol (Rome); 2014; 15(7-8):442-51. PubMed ID: 25174598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A health-economic evaluation of aspirin: primary prevention and cardiovascular disease.
    Sakai T; Saku K
    Intern Med; 2007; 46(8):431-3. PubMed ID: 17443030
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of aspirin in the primary prevention of cardiovascular disease].
    Rodondi N; Cornuz J
    Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status.
    Xie M; Shan Z; Zhang Y; Chen S; Yang W; Bao W; Rong Y; Yu X; Hu FB; Liu L
    PLoS One; 2014; 9(10):e90286. PubMed ID: 25360605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on the risk and benefit of aspirin therapy: an application of the concepts of unqualified success and unmitigated failure.
    Cragg JJ; Schulzer M; Mancini GB
    J Clin Epidemiol; 2013 Jul; 66(7):803-5. PubMed ID: 23523548
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aspirin for primary prevention of asymptomatic atherosclerosis].
    Lévesque H
    J Mal Vasc; 2002 Dec; 27(5):263-6. PubMed ID: 12525771
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin prophylaxis in people without prior cardiovascular disease does not lead to reductions in cardiovascular death or cancer mortality.
    Farooq MU; Gorelick PB
    Evid Based Med; 2013 Apr; 18(2):e14. PubMed ID: 22851620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.